Private hospitals short of emergency drugs, consultant warns
IV adrenaline, atropine and hydrocortisone are among seven emergency medicines unavailable in the private sector, Dr. Chamal Sanjeewa says.
IV adrenaline, atropine and hydrocortisone are among seven emergency medicines unavailable in the private sector, Dr. Chamal Sanjeewa says.
Health Minister says NMRA Act will be amended to cover cosmetics, with the bill due within three months.
Dr. Chamal Sanjeewa says suppliers have sought import approval for years and two doses would cost over Rs. 100,000 privately. He raised the same delay in.
A standalone CDC on Health Ministry land, plus lab and warehouse upgrades, funded by a Rs. 4.78 billion Pandemic Fund grant. Two outlets name the funder.
Price caps on 13 essential medicines produced estimated Rs. 5.7bn saving for state under NMRA regulations.
NMRA setting maximum prices on 6,000 medicines, benchmarking against India and Bangladesh retail costs.
A doctors' union says a Rs. 250 million G-CSF consignment entered Sri Lanka without meeting labelling and registration standards, and wants the NMRA to explain.
Sri Lanka's most widely used contraceptive pill scarce in pharmacies; substitutes jump from Rs. 2,500 to Rs. 6,000.
A doctors' association says 160,000 Filgrastim vials sit at MSD stores over a reverse-label defect, and that re-labelling abroad would take three months.
Doctors' union says cancer drug costing Rs. 900 is selling for over Rs. 25,000, with 100,000 units stuck over a labelling dispute.
The Sri Lankan drug manufacturer says it shipped its first consignment to Cambodia on August 14, with Vietnam and the Philippines next on its export list.
Nalinda Jayatissa told Parliament a rejected 160,000-vial consignment caused the cancer drug shortage and that airfreighted stock is being sought.
A doctors' trade union alliance alleges NMRA delays, shortages of cancer drugs and a year-long leadership vacuum at Jayawardenapura hospital.
The Private Health Services Regulatory Council says it lacks the staff to monitor expired dengue NS1 kits, and has waited 10 years for gazette approval.
Sri Lanka's NMRA has appointed an expert committee to assess registering Takeda's Qdenga dengue vaccine, days after India approved the same shot.
The CID has asked the Health Ministry to open a preliminary inquiry into substandard cardiac stents and catheters supplied to state hospitals.
Health Minister Nalinda Jayatissa says NMRA will consider a 6-7% drug price revision on June 30 as the rupee has fallen around 8% in six months.
NMRA Chairman Dr. Ananda Wijewickrama says revisions are underway for around 60 categories of gazetted drugs, with imported and local medicines likely to rise.
EDB Chairman Wijesinghe says current pharmaceutical export earnings are under USD 6 million; certification gap with foreign regulators is the chief constraint.
The WHO has begun a week-long mission to help Sri Lanka draft a national action plan against substandard, falsified and unregistered medical products.
Rupee depreciation and frozen drug price caps are squeezing pharma importers; Health Minister Jayatissa says a ceiling-price revision is under review.
Sri Lanka's Cabinet approved a USD 225,000 contract with Reliance Life Sciences for 6,000 pre-filled Adalimumab syringes used to treat autoimmune conditions.
PET scan services at Apeksha and Colombo National Hospital halted since March 27 are set to resume after NMRA approved the importer's registration.
Four Colombo residents arrested at BIA after eight suitcases of undeclared medicines from Bangalore were intercepted in the green channel.